EVOKE PHARMA, INC. Form PRE 14A: Preliminary proxy statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2024-03-29: Form PRE 14A; Period of report 2024-03-29; Description PRE 14A; Document evok-20240329.htm.
- 2023-03-17: Form PRE 14A; Description PRE 14A; Document evok-20230317.htm.
- 2022-03-04: Form PRE 14A; Period of report 2022-04-27; Description PRE 14A; Document evok-pre14a_20220427.htm.
- 2021-03-12: Form PRE 14A; Period of report 2021-05-05; Description PRE 14A; Document evok-pre14a_20210505.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2024-03-29 | PRE 14A | 2024-03-29 | PRE 14A | evok-20240329.htm |
| 2023-03-17 | PRE 14A | PRE 14A | evok-20230317.htm | |
| 2022-03-04 | PRE 14A | 2022-04-27 | PRE 14A | evok-pre14a_20220427.htm |
| 2021-03-12 | PRE 14A | 2021-05-05 | PRE 14A | evok-pre14a_20210505.htm |